Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Epidemiology and Determinants of Outcomes of Hospital Acquired Blood Stream Infections in the Intensive Care: the Eurobact II Multinational Cohort Study

NCT03937245 is registered in ClinicalTrials.gov with Outcome Rea as lead sponsor.

NCT NCT03937245
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03937245 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Epidemiology and Determinants of Outcomes of Hospital Acquired Blood Stream Infections in the Intensive Care: the Eurobact II Multinational Cohort Study
Lead sponsor
Outcome Rea
Phase
Observational
Overall status
Completed
Start date
August 30, 2019
Completion date
June 3, 2021
Enrollment
3,058 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bacteremia, hospital acquired condition, resistance bacterial, sepsis